You are here
Luye Pharma, owners eye up to US$764m from HK IPO
[SINGAPORE] Luye Pharma Group Ltd, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and existing owners are seeking to raise as much as US$764 million from a Hong Kong initial public offering.
The company and its investors are selling 999.6 million shares at HK$5.38 to HK$
- CALL +65 6388 3838
- EMAIL email@example.com